About UsUnderstanding AMLInterviewsGlobal NetworkGet InvolvedStoriesResources

What are the benefits & risks of avoiding high-dose chemotherapy?

Jacqueline Garcia

December 7, 2020

During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, Know AML spoke to Jacqueline Garcia, Dana-Farber Cancer Institute, Boston, US, about the benefits and risks of avoiding high-dose chemotherapy. Garcia explains that high-dose chemotherapy is not the best therapy for all patients. She also gives an overview of the alternative therapies available for patients who are unable to receive high-dose chemotherapy.